Regeneron Pharmaceuticals, Inc.

MACKENZIE FINANCIAL CORP REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/18/2026

Shares

78,736

Value ($000)

60,817

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/18/2026	60,817	0.1%	78,736	12/31/2025
2025 Q3	11/13/2025	72,321	0.1%	128,623	9/30/2025
2025 Q2	8/13/2025	53,244	0.1%	101,418	6/30/2025
2025 Q1	5/7/2025	42,468	0.1%	66,960	3/31/2025
2024 Q4	2/14/2025	38,177	0.1%	55,032	12/31/2024
2024 Q3	11/13/2024	58,861	0.1%	55,992	9/30/2024
2024 Q2	8/14/2024	60,922	0.1%	57,964	6/30/2024
2024 Q1	5/10/2024	53,794	0.1%	55,890	3/31/2024
2023 Q4	1/30/2024	49,435	0.1%	56,285	12/31/2023
2023 Q3	10/25/2023	45,545	0.1%	56,346	9/30/2023
2023 Q2	8/3/2023	42,830	0.1%	59,644	6/30/2023
2023 Q1	4/24/2023	54,814	0.1%	66,710	3/31/2023
2022 Q4	2/14/2023	51,910	0.1%	71,949	12/31/2022
2022 Q3	10/7/2022	56,305	0.1%	81,736	9/30/2022
2022 Q2	8/10/2022	52,757	0.1%	89,248	6/30/2022
2022 Q1	5/13/2022	65,589	0.1%	93,910	3/31/2022
2021 Q4	2/14/2022	55,705	0.1%	88,208	12/31/2021
2021 Q3	11/8/2021	53,601	0.1%	88,570	9/30/2021
2021 Q2	8/11/2021	49,403	0.1%	88,451	6/30/2021
2021 Q1	5/14/2021	33,200	0.1%	70,169	3/31/2021
2020 Q4	2/10/2021	17,813	0.0%	36,872	12/31/2020
2020 Q3	11/13/2020	17,581	0.0%	31,407	9/30/2020
2020 Q2	8/13/2020	14,520	0.0%	23,282	6/30/2020
2020 Q1	5/14/2020	9,161	0.0%	18,761	3/31/2020
2019 Q4	2/13/2020	6,822	0.0%	18,168	12/31/2019